Orionis Biosciences BV
Patent Applications and Registrations
Patent applications and USPTO patent grants for Orionis Biosciences BV.The latest application filed is for "targeted chimeric proteins and uses thereof".
- Orionis Biosciences BV - Zwijnaarde N/A BE
- Orionis Biosciences BV - Ghent BE
- Orionis Biosciences BV - Chent BE
- Orionis Biosciences BV - Zwinjnaarde BE
| Patent | Date |
|---|---|
| Therapeutic interferon alpha 1 proteins Grant 11,440,943 - Kley , et al. September 13, 2 | 2022-09-13 |
| Targeted Chimeric Proteins And Uses Thereof App 20220281992 - KLEY; Nikolai ; et al. | 2022-09-08 |
| Combination Therapy With Cd13-targeted Chimeric Proteins Or Chimeric Protein Complexes App 20220249609 - KLEY; Nikolai ; et al. | 2022-08-11 |
| Targeted chimeric proteins and uses thereof Grant 11,384,154 - Kley , et al. July 12, 2 | 2022-07-12 |
| Chimeric Proteins And Chimeric Protein Complexes Directed To Fms-like Tyrosine Kinase 3 (flt3) App 20220177550 - KLEY; Nikolai ; et al. | 2022-06-09 |
| Cd8 Binding Agents App 20220177586 - KLEY; Nikolai ; et al. | 2022-06-09 |
| Clec9a-based Chimeric Protein Complexes App 20220153801 - KLEY; Nikolai ; et al. | 2022-05-19 |
| Sirp1a Targeted Chimeric Proteins And Uses Thereof App 20220119519 - KLEY; Nikolai ; et al. | 2022-04-21 |
| Modulation Of Dendritic Cell Lineages App 20220119472 - KLEY; Nikolai ; et al. | 2022-04-21 |
| Targeted Mutant Interferon-beta And Uses Thereof App 20220089668 - KLEY; Nikolai ; et al. | 2022-03-24 |
| Targeted mutant interferon-beta and uses thereof Grant 11,236,141 - Kley , et al. February 1, 2 | 2022-02-01 |
| CD8 binding agents Grant 11,236,166 - Kley , et al. February 1, 2 | 2022-02-01 |
| Targeted Mutant Interferon-gamma And Uses Thereof App 20210403525 - KLEY; Nikolai ; et al. | 2021-12-30 |
| Targeted Therapeutic Agents And Uses Thereof App 20210388088 - TAVERNIER; Jan ; et al. | 2021-12-16 |
| Targeted mutant interferon-gamma and uses thereof Grant 11,084,859 - Kley , et al. August 10, 2 | 2021-08-10 |
| Targeted Engineered Interferon And Uses Thereof App 20210230291 - KLEY; Nikolai ; et al. | 2021-07-29 |
| Bispecific Signaling Agents And Uses Thereof App 20210139586 - KLEY; Nikolai ; et al. | 2021-05-13 |
| Clec9A binding agents Grant 11,001,631 - Tavernier , et al. May 11, 2 | 2021-05-11 |
| Bispecific signaling agents and uses thereof Grant 10,988,538 - Kley , et al. April 27, 2 | 2021-04-27 |
| Targeted engineered interferon and uses thereof Grant 10,906,985 - Kley , et al. February 2, 2 | 2021-02-02 |
| Bi-functional Proteins And Construction Thereof App 20210024631 - KLEY; Nikolai ; et al. | 2021-01-28 |
| Therapeutic Interferon Alpha 1 Proteins App 20200308244 - KLEY; Nikolai ; et al. | 2020-10-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 